期刊文献+

一种复合生物消毒剂的研制 被引量:1

Development of compound bio-disinfector
下载PDF
导出
摘要 目的 :研制一种安全性高的复合型生物消毒剂。方法 :筛选安全性高的生物消毒剂,进行最小杀菌浓度(minimum bactericidal concentration,MBC)测试,选择消毒性高的消毒剂,并辅以合适的表面活性剂和助剂,通过正交设计,确定高效的生物消毒剂配方。参考《消毒技术规范》的规定对不同配方进行消毒效果评价;将消毒剂配方于54℃保存3个月,测试其长期保存后的消毒效果。结果:获得了组分为5 mg/mlε-聚赖氨酸、1%甜菜碱表面活性剂(BS-12)、5 mg/ml甘氨酸和0.2%甘油的复合型生物消毒剂配方,其在3 min内对大肠杆菌、金黄色葡萄球菌、绿脓杆菌的消毒对数值均大于4,消毒效果理想。加速试验结果表明,该消毒剂放置2 a消毒效果保持不变。结论:该生物消毒剂具有优良的消毒效果,可以用于物体表面等的消毒。 Objective To prepare a compound bio-disinfector with high safety. Methods Minimum bactericidal concentration(MBC) test was used to select a high-efficiency disinfector from several high-safety ones, and then proper surfactant and promoter as well as orthogonal design were involved in to determine the bio-disinfector remedies. The efficacies of bio-disinfectors with different remedies were evaluated according to Disinfection Technical Specifications. The prepared disinfector underwent 3-month storage at 54 ℃, and then was tested on disinfection efficacy after long-term storage. Results The developed disinfector involved in 5 mg/ml ε-polylysine, 1% BS-12, 5 mg/ml Gly and 0.2% glycerol, which had the logarithm value higher than 4 when used to disinfect escherichia coli, staphylococcus aureus pseudomonas aeruginosa.Accelerated test proved the prepared disinfector was still efficient after 2-year storage. Conclusion The disinfector behaves well in the disinfection of surface and etc.
作者 郝丽梅 衣颖 林松 吴金辉 HAO Li-mei YI Ying LIN Song WU Jin-hui(Institute of Medical Equipment, Academy of Military Medical Sciences, Tianjin 300161, China)
出处 《医疗卫生装备》 CAS 2017年第1期6-9,14,共5页 Chinese Medical Equipment Journal
基金 军队医学科技青年培育项目(13QNP155) 军队后勤科研项目(AWS13C007)
关键词 Ε-聚赖氨酸 复合生物消毒剂 杀菌 消毒 抗菌剂 ε-polylysine compound bio-disinfector sterilization disinfection disinfector
  • 相关文献

参考文献2

二级参考文献39

  • 1Sanders CC, Sanders WE Jr, Moland ES. Decimal assay for additivity of drugs permits delineation of synergy and antagonism. Antimicrob Agents Chemother, 1993,37(2) :260-264.
  • 2Polak A. Combination of amorolfine with various antifungal drugs in dermatophytosis. Mycoses, 1993,36(1-2) :43-49.
  • 3Baran R, Feuilhade M, Datry A, et al. A randomized trial of amorolfine5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol, 2000, 142(6): 1177-1183.
  • 4Barchiesi F, Falconi Di Francesco L, Scaliso G. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antiricrob Agents Chemother, 1997,41(8): 1812-1814.
  • 5Barchiesi F, Di Francesco LF, Compagnucei P, et al. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother, 1998,41(1) :59-65.
  • 6Ryder NS. Activity of terbinafine against serious fungal pathogens. Mycoses, 1999,42(Suppl 2):115-119.
  • 7Shenep JL, English K, Kaufnmn L, et al. Successful medical therapy for deeply invasive facial infection due to Pythiuminsidiosum. Clin Infect Dis,1999,27:1812-1814.
  • 8Sanyal AK, Roy D, Chowdhury B, et al. Ibuprofen, an unique anti-inflammatory compound activity against dermatophytes. Lett Appl Microbiol,1993,17:109-111.
  • 9Scott EM, Tariq VN, McCrory RM, et al. Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother, 1995,39(12) :2610-2614.
  • 10Tariq VN, Scott EM, McCain NE , et al. Use of decinal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother, 1995,39(12) :2615-2619.

共引文献24

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部